Abstract:The functional human immunodeficiency virus (HIV-1) envelope glycoprotein (Env) trimer [(gp120/gp41)3] is produced by cleavage of a conformationally flexible gp160 precursor. gp160 cleavage or the binding of BMS-806, an entry inhibitor, stabilizes the pretriggered, "closed" (state 1) conformation recognized by rarely elicited broadly neutralizing antibodies. Poorly neutralizing antibodies (pNAbs) elicited at high titers during natural infection recognize more "open" Env conformations (states 2 and 3) induced by binding the receptor, CD4. We found that BMS-806 treatment and cross-linking decreased the exposure of pNAb epitopes on cell surface gp160; however, after detergent solubilization, cross-linked and BMS-806-treated gp160 sampled non-state-1 conformations that could be recognized by pNAbs. Cryo-electron microscopy of the purified BMS-806-bound gp160 revealed two hitherto unknown asymmetric trimer conformations, providing insights into the allosteric coupling between trimer opening and structural variation in the gp41 HR1N region. The individual protomer structures in the asymmetric gp160 trimers resemble those of other genetically modified or antibody-bound cleaved HIV-1 Env trimers, which have been suggested to assume state-2-like conformations. Asymmetry of the uncleaved Env potentially exposes surfaces of the trimer to pNAbs. To evaluate the effect of stabilizing a state-1-like conformation of the membrane Env precursor, we treated cells expressing wild-type HIV-1 Env with BMS-806. BMS-806 treatment decreased both gp160 cleavage and the addition of complex glycans, implying that gp160 conformational flexibility contributes to the efficiency of these processes. Selective pressure to maintain flexibility in the precursor of functional Env allows the uncleaved Env to sample asymmetric conformations that potentially skew host antibody responses toward pNAbs. IMPORTANCE The envelope glycoprotein (Env) trimers on the surface of human immunodeficiency virus (HIV-1) mediate the entry of the virus into host cells and serve as targets for neutralizing antibodies. The functional Env trimer is produced by cleavage of the gp160 precursor in the infected cell. We found that the HIV-1 Env precursor is highly plastic, allowing it to assume different asymmetric shapes. This conformational plasticity is potentially important for Env cleavage and proper modification by sugars. Having a flexible, asymmetric Env precursor that can misdirect host antibody responses without compromising virus infectivity would be an advantage for a persistent virus like HIV-1.

Structures and Immune Recognition of Env Trimers from Two Asia Prevalent HIV-1 CRFs

Stabilized Diverse HIV-1 Envelope Trimers for Vaccine Design.

Structural insights into the conformational plasticity of the full-length trimeric HIV-1 envelope glycoprotein precursor

Structure and Immune Recognition of Trimeric Pre-Fusion HIV-1 Env.

Short Communication: in VitroSynergy Between Peptides or Neutralizing Antibodies Targeting the N- and C-Terminal Heptad Repeats of HIV Type 1 Gp41

Asymmetric conformations of cleaved HIV-1 envelope glycoprotein trimers in styrene-maleic acid lipid nanoparticles

Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer

Asymmetric Structures and Conformational Plasticity of the Uncleaved Full-Length Human Immunodeficiency Virus Envelope Glycoprotein Trimer.

Cryo-ET of Env on intact HIV virions reveals structural variation and positioning on the Gag lattice

Contemporary HIV-1 consensus Env with AI-assisted redesigned hypervariable loops promote antibody binding

[Progress in HIV-1 Env Trimer Design].

Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer

Conformational dynamics of the HIV-1 envelope glycoprotein from CRF01_AE is associated with susceptibility to antibody-dependent cellular cytotoxicity

Antigenic analysis of the HIV-1 envelope trimer implies small differences between structural states 1 and 2

A sequestered fusion peptide in the structure of an HIV-1 transmitted founder envelope trimer

Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted/founder sensitivity to broadly neutralizing antibodies

Molecular Architecture of the Uncleaved HIV-1 Envelope Glycoprotein Trimer

Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaques

Genetic and Phenotypic Analysis of CRF01_AE HIV-1envClones from Patients Residing in Beijing, China

Subunit Organization of the Membrane-Bound HIV-1 Envelope Glycoprotein Trimer

Structural Delineation of a Quaternary, Cleavage-Dependent Epitope at the Gp41-Gp120 Interface on Intact HIV-1 Env Trimers.